Holen Sie sich die Stockscreener-App
3.88
14.79%
0.50
Schlusskurs vom Vortag:
$3.38
Offen:
$3.42
24-Stunden-Volumen:
10.68M
Relative Volume:
2.08
Marktkapitalisierung:
$928.33M
Einnahmen:
$251.85M
Nettoeinkommen (Verlust:
$-72.58M
KGV:
-12.38
EPS:
-0.3134
Netto-Cashflow:
$-63.80M
1W Leistung:
+7.18%
1M Leistung:
-15.65%
6M Leistung:
-21.93%
1J Leistung:
-50.19%
1-Tages-Spanne:
$3.42
$4.04
1-Wochen-Bereich:
$3.21
$4.04
52-Wochen-Spanne:
$3.21
$8.06
Ardelyx Inc Stock (ARDX) Company Profile
Firmenname
Ardelyx Inc
Sektor
Branche
Telefon
510-745-7047
Adresse
34175 ARDENWOOD BLVD., FREMONT, CA
Vergleichen Sie ARDX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ARDX
Ardelyx Inc
|
3.88 | 866.10M | 251.85M | -72.58M | -63.80M | -0.3134 |
|
ONC
Beigene Ltd Adr
|
228.38 | 25.07B | 3.81B | -644.79M | -669.77M | -6.24 |
|
VRTX
Vertex Pharmaceuticals Inc
|
438.65 | 109.14B | 11.10B | -988.90M | -1.26B | -3.92 |
|
AKTX
Akari Therapeutics Plc Adr
|
1.27 | 36.39M | 0 | 0 | 0 | 0.00 |
|
REGN
Regeneron Pharmaceuticals Inc
|
594.32 | 56.98B | 14.09B | 4.50B | 2.96B | 39.28 |
|
VRNA
Verona Pharma Plc Adr
|
71.31 | 5.39B | 0 | -153.72M | -103.81M | -2.00 |
Ardelyx Inc Stock (ARDX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-05-02 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2025-03-07 | Fortgesetzt | Ladenburg Thalmann | Buy |
| 2025-03-04 | Eingeleitet | BTIG Research | Buy |
| 2024-11-11 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2024-07-02 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2024-04-05 | Eingeleitet | Leerink Partners | Outperform |
| 2023-12-18 | Eingeleitet | Raymond James | Strong Buy |
| 2023-09-07 | Eingeleitet | H.C. Wainwright | Buy |
| 2023-08-25 | Hochstufung | Cantor Fitzgerald | Neutral → Overweight |
| 2023-03-03 | Hochstufung | Wedbush | Neutral → Outperform |
| 2022-11-17 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2022-05-06 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
| 2021-12-01 | Hochstufung | Ladenburg Thalmann | Neutral → Buy |
| 2021-10-14 | Herabstufung | Ladenburg Thalmann | Buy → Neutral |
| 2021-07-21 | Herabstufung | Jefferies | Buy → Hold |
| 2021-07-20 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2021-07-20 | Herabstufung | Wedbush | Outperform → Neutral |
| 2021-03-23 | Eingeleitet | Wedbush | Outperform |
| 2021-01-06 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2020-10-20 | Fortgesetzt | Citigroup | Buy |
| 2020-02-18 | Fortgesetzt | Jefferies | Buy |
| 2020-02-12 | Eingeleitet | Citigroup | Buy |
| 2020-02-10 | Eingeleitet | Cowen | Outperform |
| 2019-04-08 | Eingeleitet | Piper Jaffray | Overweight |
| 2018-08-24 | Eingeleitet | Jefferies | Buy |
| 2018-03-19 | Fortgesetzt | Leerink Partners | Outperform |
| 2017-11-29 | Bestätigt | Citigroup | Buy |
| 2017-11-22 | Bestätigt | Ladenburg Thalmann | Buy |
| 2017-10-17 | Fortgesetzt | Leerink Partners | Outperform |
| 2016-03-31 | Eingeleitet | Ladenburg Thalmann | Buy |
| 2016-03-09 | Eingeleitet | Cantor Fitzgerald | Buy |
| 2016-03-03 | Eingeleitet | Citigroup | Buy |
Alle ansehen
Ardelyx Inc Aktie (ARDX) Neueste Nachrichten
The Manufacturers Life Insurance Company Sells 130,801 Shares of Ardelyx, Inc. (NASDAQ:ARDX) - Defense World
Benign Growth For Ardelyx, Inc. (NASDAQ:ARDX) Underpins Stock's 28% Plummet - simplywall.st
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ardelyx, Inc. - Bluefield Daily Telegraph
Investors Who Lost Money on Ardelyx, Inc. Should Contact Levi & Korsinsky About an Ongoing InvestigationARDX - ACCESS Newswire
Investors who Lost Money on Ardelyx, Inc. Should Contact Levi & Korsinsky About an Ongoing InvestigationARDX - ACCESS Newswire
Ardelyx, Inc. (NASDAQ:ARDX) Receives Average Recommendation of “Moderate Buy” from Brokerages - Defense World
Levi & Korsinsky Investigates Possible Securities Fraud Violations by Ardelyx, Inc. (ARDX) - ACCESS Newswire
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of October 15, 2024 in Ardelyx LawsuitARDX - ACCESS Newswire
Ardelyx, Inc. INVESTIGATION: Levi & Korsinsky Investigates Potential Securities Fraud by Ardelyx, Inc. (ARDX) - ACCESS Newswire
David Mott Bought 19% More Shares In Ardelyx - simplywall.st
Shareholders that lost money on Ardelyx, Inc.(ARDX) should contact Levi & Korsinsky about pending Class ActionARDX - ACCESS Newswire
Ardelyx, Inc. Class Action: Levi & Korsinsky Reminds Ardelyx Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 15, 2024ARDX - ACCESS Newswire
Levi & Korsinsky Notifies Shareholders of Ardelyx, Inc.(ARDX) of a Class Action Lawsuit and an Upcoming Deadline - ACCESS Newswire
Ardelyx, Inc. Sued for Securities Law ViolationsInvestors Should Contact Levi & Korsinsky for More InformationARDX - ACCESS Newswire
Investors who lost money on Ardelyx, Inc.(ARDX) should contact Levi & Korsinsky about pending Class ActionARDX - ACCESS Newswire
Shareholders that lost money on Ardelyx, Inc. (ARDX) Urged to Join Class ActionContact Levi & Korsinsky to Learn More - ACCESS Newswire
ARDX LAWSUIT ALERT: Levi & Korsinsky Notifies Ardelyx, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - ACCESS Newswire
Shareholders that lost money on Ardelyx, Inc.(ARDX) Urged to Join Class Action – Contact Levi & Korsinsky to Learn More - ACCESS Newswire
Shareholders that lost money on Ardelyx, Inc.(ARDX) Urged to Join Class ActionContact Levi & Korsinsky to Learn More - ACCESS Newswire
Ardelyx, Inc. Sued for Securities Law Violations – Investors Should Contact Levi & Korsinsky for More InformationARDX - ACCESS Newswire
Levi & Korsinsky Reminds Ardelyx, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 15, 2024ARDX - ACCESS Newswire
Ardelyx, Inc. Investigation Ongoing: Contact Levi & Korsinsky to Discuss Your RightsARDX - ACCESS Newswire
(ARDX) Technical Pivots with Risk Controls - news.stocktradersdaily.com
Ardelyx downgraded at Raymond James after Q1 sales miss - MSN
Ardelyx presents data supporting IBSRELA at DDW 2025 - TipRanks
Ardelyx First Quarter 2025 Earnings: Misses Expectations - Yahoo Finance
Hedge Fund and Insider Trading News: Paul Tudor Jones, Warren Buffett, John Paulson Bill Ackman, Platinum Asset Management, Ardelyx Inc (ARDX), Stem Inc (STEM), and More - Insider Monkey
Ardelyx Presents Data Supporting IBSRELA® (tenapanor) at Digesti - GuruFocus
Ardelyx (ARDX) Highlights IBSRELA's Efficacy at Digestive Diseas - GuruFocus
Ardelyx (ARDX) Highlights IBSRELA's Efficacy at Digestive Disease Week Conference | ARDX Stock News - GuruFocus
Ardelyx showcases IBSRELA data at Digestive Disease Week - Investing.com Australia
Ardelyx showcases IBSRELA data at Digestive Disease Week By Investing.com - Investing.com South Africa
Ardelyx Presents Data Supporting IBSRELA® (tenapanor) at Digestive Disease Week 2025 Conference - TradingView
Triple Study Results: IBSRELA IBS-C Drug Proves Safe for Teens and Nursing Mothers at DDW 2025 - Stock Titan
Ardelyx, Inc. (NASDAQ:ARDX) Q1 2025 Earnings Call Transcript - Insider Monkey
Ardelyx Inc Reports Strong Growth Amid Challenges - MSN
Ardelyx targets $240M-$250M in IBSRELA 2025 sales amid strong Q1 growth - MSN
Analysts Have Been Trimming Their Ardelyx, Inc. (NASDAQ:ARDX) Price Target After Its Latest Report - Yahoo Finance
Raymond James cuts Ardelyx stock rating, lowers target to $11 By Investing.com - Investing.com Canada
Ardelyx (ARDX) Price Target Lowered by Citigroup to $10.00 | ARDX Stock News - GuruFocus
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Ardelyx, Inc.(ARDX) Shareholders - ACCESS Newswire
Ardelyx Inc earnings missed by $0.06, revenue fell short of estimates - Investing.com Australia
Raymond James cuts Ardelyx stock rating, lowers target to $11 - Investing.com Australia
Ardelyx (ARDX) Faces Downgrade Amid Revenue Shortfall - GuruFocus
Ardelyx's Q1 Loss Widens; Shares Fall - marketscreener.com
Ardelyx stock downgraded at Raymond James (ARDX:NASDAQ) - Seeking Alpha
Ardelyx: Revenue Misses And Losses Widen Amid XPHOZAH Uncertainty (NASDAQ:ARDX) - Seeking Alpha
Stocks in play: SECURE Waste Infrastructure Corp. - The Globe and Mail
Block, Atlassian, Apple, Roku, Amazon And Other Big Stocks Moving Lower In Friday's Pre-Market Session - Benzinga
Raymond James Downgrades Ardelyx to Outperform From Strong Buy, Adjusts Price Target to $11 From $13 - marketscreener.com
Ardelyx (ARDX) Downgraded by Raymond James Amid Sales Concerns | - GuruFocus
Finanzdaten der Ardelyx Inc-Aktie (ARDX)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.54%
7.58%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):